TFCP2L1 and cancer: Co‐expression of p‐TFCP2L1 and CDK1 was an independent prognostic factor (P = 0.010) of cancer‐specific survival in multivariate analysis, in addition to age, lymph node metastasis, and muscularis propria invasion (Fig 4B).